DOI:

10.37988/1811-153X_2021_1_60

Combined antimicrobial chemotherapy (fluoroquinolones and imidazoles) in the complex treatment of inflammatory diseases of the periodontal

Authors

  • R.V. Ushakov 1, PhD in Medical Sciences, full professor of the General and surgical dentistry Department
    ORCID ID: 0000-0003-4821-1758
  • N.N. Nuruev 1, senior laboratory technician at the General and surgical dentistry Department
    ORCID ID: 0000-0002-4417-4788
  • T.V. Ushakova 1, PhD in Medical Sciences, associate professor of the General and surgical dentistry Department
    ORCID ID: 0000-0002-4957-6831
  • V.M. Karpova 2, PhD in Medical Sciences, associate professor of the Dentistry diseases propaedeutics Department
    ORCID ID: 0000-0003-1003-6667
  • A.A. Arutyunjan 2, senior laboratory technician at the Microbiology, virology, immunology Department
    ORCID ID: 0000-0002-8485-5975
  • A.A. Labazanov 2, PhD in Medical Sciences, dental surgeon, researcher at the Molecular biology research laboratory of the Medico-dental research Institute
    ORCID ID: 0000-0003-2002-6403
  • V.N. Tsarev 2, PhD in Medical Sciences, full professor of the Microbiology, virology, immunology Department
    ORCID ID: 0000-0002-3311-0367
  • 1 Russian Medical Academy of Continuous Professional Education, 125993, Moscow, Russia
  • 2 Moscow State University of Medicine and Dentistry, 127473, Moscow, Russia

Abstract

In inflammatory periodontal diseases, the leading role in the emergence and development of the process is assigned to the microbial biofilm; therefore one of the requirements for antibiotics used in periodontology is the ability of the drug to easily penetrate into the microbial biofilm. The aim is to study the effect of a combination of drugs of the fluoroquinolone group — ciprofloxacin and the 5-nitroimidazole group — tinidazole on the clinical manifestations and microbial composition of biofilms in chronic generalized periodontitis.
Materials and methods.
58 patients with exacerbation of moderate chronic periodontitis were examined. In the main group, a combined preparation of ciprofloxacin and tinidazole (Tsifran ST) was prescribed, in the comparison group — amoxicillin with clavulanic acid (Amoxiclav). The duration of the course of antimicrobial chemotherapy was 10—12 days.
Results.
In the course of treatment, normalization of the indices of hygiene indices, PMA and PBI in both groups was established. Representatives of the consortium P. gingivalis, T. forsythia, A. actinomycetemcomitans were identified by PCR diagnostics in 100% of patients in both groups. complex treatment of chronic generalized periodontitis with a combination of ciprofloxacin and tinidazole increases the efficiency of eradication of the periodontal pocket and tissues of the periodontal complex from periodontal pathogenic bacterial species. After the treatment, the eradication of periodontal pathogenic species in the main group (use of a combination of ciprofloxacin and tinidazole) was more complete than in the comparison group, and dysbiotic disorders were less pronounced than in the comparison group.
Conclusion.
The inclusion of a combination of ciprofloxacin and tinidazole in the algorithms for the complex treatment of chronic generalized periodontitis increases the efficiency of eradication of the periodontal pocket and tissues of the periodontal complex from periodontal pathogenic bacteria species.

Key words:

chronic periodontitis, biofilm, systemic antibacterial chemotherapy, ciprofloxacin, tinidazole, amoxicillin

For Citation

[1]
Ushakov R.V., Nuruev N.N., Ushakova T.V., Karpova V.M., Arutyunjan A.A., Labazanov A.A., Tsarev V.N. Combined antimicrobial chemotherapy (fluoroquinolones and imidazoles) in the complex treatment of inflammatory diseases of the periodontal. Clinical Dentistry (Russia).  2021; 1 (97): 60—65. DOI: 10.37988/1811-153X_2021_1_60

Introduction

A special place in the complex treatment of chronic generalized periodontitis is played by antimicrobial therapy, which, according to most researchers, should be aimed at: elimination of acute inflammatory process (exacerbation); antimicrobial sanitation of periodontal tissues; changing the ratio between pathogenic (periodontopathogenic) and non-pathogenic (stabilizing) microflora towards the latter's side; prevention of systemic and local infectious complications, including those arising from invasive interventions; prevention of the development of superinfection, including fungal lesions; reducing the level of microbial "load" and thereby helping the body to fight infection [1—5].

Without undervaluing the role of personal and professional oral hygiene and local drug treatment in periodontal diseases, which are given a significant place in the modern literature [1, 6—8], it should be noted that mechanical (physical) treatment and local antimicrobial action does not allow to altogether remove periodontal pathogenic microbes from the tissues in the developed inflammatory process, primarily due to their intracellular localization and the formed multilayered microbial biofilm [3, 9].

Therefore, the combination of mechanical removal of microbes together with the systemic administration of antimicrobial chemotheraputics and antibiotics is considered the most effective method of complex treatment. the basis for conducting systemic antimicrobial therapy in the treatment of periodontitis is unstable and insufficient sanitation of periodontal pockets (periodontal complex tissues) from representatives of periodontal pathogenic species during professional hygiene and using only local antibacterial therapy [3, 5, 9—11].

Alongside this, a multiple resistance of some periodontal pathogens (P. gingivalis, A. actinomycetemcomitans, T. forsythia, P. intermedia, T. denticola, etc.) is noted to antimicrobial chemotherapy drugs [12—17]. In this regard, in addition to monotherapy (the appointment of a single drug), a combination of antibacterial chemotheraputics is widely used in mixed infections, which includes periodontitis, which makes it possible to cover the possible spectrum of resistance to antibiotics from the microorganisms [1, 2, 5, 10, 11].

As is known, in inflammatory periodontal diseases, the leading role in the occurrence and development of the process is assigned to the microbial biofilm, which contains periodontopathogenic species of the red and orange complex, according to S.S. Socransky (1997) [18]. Therefore, one of the requirements for antibiotics used in periodontology is the drug's ability to easily penetrate inside through the microbial biofilm's protective cover, affecting microbes in all phases of biofilm formation [3, 7, 11].

The group of medicament that penetrates the microbial biofilm includes, in particular, fluoroquinolones and 5-nitroimidazoles, which have high, although unequal, activity against the main periodontal pathogenic species. Besides, the combination of drugs of these groups has a synergistic effect [19—22].

In this regard, the work aimed to study the effect of a combination of a chemotherapy drug of the fluoroquinolone group (Ciprofloxacin) and a group of 5-nitroimidazole (Tinidazole) on the clinical manifestations and microbial composition of the biofilm in chronic generalized periodontitis.

Materials and methods

58 patients with exacerbation of chronic generalized periodontitis of moderate severity were examined. the diagnosis of CGP was made following the Russian Clinical recommendations (treatment protocols) for the diagnosis of periodontitis, 2014. All patients underwent professional hygiene following Clinical recommendations (protocols), if necessary — correction of occlusion.

In the group I (main) a combined drug of 500 mg of Ciprofloxacin with 600 mg of Tinidazole (Cifran СT) was prescribed, in the II group (comparison) — Amoxicillin with clavulanic acid (Amoxiclav). the duration of the course of antimicrobial therapy was 10—12 days.

To assess the condition of periodontal disease, we used the simplified Greene—Vermillion index of oral hygiene, the papillary-marginal-alveolar index in the modification of Parma (PMA) to assess the intensity of gingivitis, and the Mühlemann—Saxer papillary bleeding index (PBI), which allows us to judge the severity of inflammation.

The values of periodontal indices were determined in each patient three times: before professional hygiene and after 10—12 days (after the end of the antimicrobial chemotherapy course). When assessing the main parameters of the state of the periodontal complex tissues, the latest international recommendations on periodontics of the EFP/ORCA workshop were taken into account [23].

According to standard protocols, isolation and cultivation of the isolated strains were carried out after microbial culture before treatment and on the 12th day. After taking the material (biofilm) from the periodontal pocket, microbial culture was carried out. Primary inoculation for the isolation of gram-negative facultative anaerobic bacteria and the microaerophilic group's representatives was carried out on a growth medium M832 (HiMediaLabs, India) — anaerobic agar according to Wilkins—Chalgren with the addition of 5% blood.

The culture was placed in a thermostat at 37°C for 120 hours, after being placed in an anaerostat HiAnaerobic System Mark III (Himedia Labs, India). After obtaining a pure culture, identification was performed using the sets of Biochemical Identification TestKits (Himedia Labs, India). A modification of the serial dilution method was used to determine the sensitivity of the isolated strains to the studied films' action [3].

In the statistical processing of the results, the quantitative values are presented in the median (Me) and quartiles (Q25; Q75). the "K-means" clustering method was used to determine high and low values intervals. the Shapiro—Wilk criterion determined the correspondence of the sample distributions to the normality conditions. the Mann—Whitney test was used to estimate the difference in related indicators. Differences with a probability of differences p<0.05 were considered statistically significant.

Results

During the clinical examination after treatment, patients of both groups showed an improvement in periodontal tissues' clinical condition, which was reflected in a statistically significant decrease in index indicators (Table. 1), which approached the level of healthy individuals. the values of OHI-S, PMA, and PBI decreased in group I by 6.6, 3, and 4 times, respectively; in group II — 6, 2 and 1.6 times, respectively. Meanwhile, statistically significant differences were found between the groups in terms of changes in the PMA index, which characterizes the intensity of the inflammatory reaction (p=0.029): in the main group, its decrease was more pronounced than in the comparison group, as well as in the PBI bleeding index. There were no significant differences between the groups in terms of hygiene indices (p=0.507 and p=0.215, respectively).

Table 1. Index assessment of the periodontal condition in patients with chronic generalized periodontitis before and after treatment by comparison groups: I — with Ciprofloxacin/Tinidazole, II — with Amoxicillin/sodium clavulanate (Me [Q25; Q75])
Parameter Before treatment After treatment
I II I II
OHI-S 2.2
[1.7; 2.3]
2.0
[1.5; 2.2]
0.1
[0.1; 0.2]
0.2
[0.1; 0.4]
РМА index, % 60.0
[47.0; 66.7]
49.7
[33.3; 56.7]
18.0
[4.0; 20.0]
23.3
[13.3; 26.7]
PBI 1.5
[1.0; 2.0]
1.1
[1.0; 1.7]
0.2
[0.1; 0.8]
0.7
[0.4; 1.0]

Note: Differences before and after treatment and between groups after treatment are statistically significant (p<0.05)

To adequately characterize the effect of antimicrobial chemotherapy in the comparison groups on the pathogens and microbiocenosis of periodontal pockets, the total degree of microbial contamination, the frequency of detection of periodontal pathogens and residents, as well as fungi of the genus Candida were evaluated with an assessment of the degree of contamination with yeast fungi (Table 2).

Table 2. Microbiological indicators in the dynamics of treatment in comparison groups (I — with Ciprofloxacin/Tinidazole, II — with Amoxicillin/sodium clavulanate 675/125 mg)
Parameter Before treatment After 2 weeks After 1 month
I II I II I II
Bacterial contamination, lg CFU/ml 9.7±0.5 9.5±0.5 5.1±0.3* 5.4±0.4* 5.2±0.4** 6.3±0.5*
Normobiota detection rate, % 100 100 86.2* 68.9* 100.0** 82.8*
Frequency of detection of periodontal pathogens, % 100 100 13.8* 17.2* 17.2** 51.7*
The frequency of detection of Candida spp., % 17.2 13.8 20.7 31.0* 13.8** 24.1
Candida spp. contamination, lg CFU/ml 2.6±0.4 2.4±0.3 3.4±0.5** 4.8±0.5* 2.6±0.4** 4.2±0.4

Note: * statistically significant difference in the groups compared to the previous control period; ** statistically significant difference from group II indicators (p<0.05).

It was found that the total degree of microbial contamination (more than 109 CFU/ml) corresponded to a high level of microbial contamination compared to the established norm (5—6 lg CFU/ml) [3].

Prior to the start of periodontal treatment, representatives of periodontal pathogenic species of the 1st order (at least one of P. gingivalis, T. forsythia, A. actinomycetemcomitans) were identified by PCR diagnostics in 100% of patients in both groups. Representatives of Candida spp. microbial culture were also determined in 13.8 and 17.2% of both groups' patients (the differences are not significant).

We drew attention to the fact that after periodontal treatment, against the background of systemic combined chemotherapy in 2 weeks, both groups observed a statistically significant decrease in the degree of microbial contamination to a normal level, and not only due to the eradication of periodontal pathogens, but also partially-residents (α-green streptococci and Corynebacteria). the frequency of detecting these crucial components of microbiocenosis decreased from 100% to 68.9 and 86.2% for group II and I, respectively. At the same time, there were significant differences in Candida spp., the indicator of which was 1.5 times higher in group II, and the frequency increased 2.4 times compared to group I.

In the control period after 1 month, the differences in the composition of microbiocenosis were partially levelled. However, in group I, the indicators were more favourable: the total microbial contamination was significantly lower, and the resident microbiota was detected in all treated patients, the frequency of detection of periodontal pathogens was 3 times lower, and yeast fungi — 1.7 times lower than in group II (p<0.05).

Thus, it can be argued that after 10—12 days of the systemic use of the antibiotic, a pronounced dysbiotic shift was observed with an increase in the population of yeast fungi, which after 1 month normalized in group I but persisted in group II.

As a clinical example, we can cite microbiological studies' results with data on the sensitivity of bacteria to antimicrobial chemotherapy drugs.

Clinical case 1

Patient G., 67 years old, with moderate exacerbation of CGP. Before treatment, the material was taken from the periodontal pocket for microbiological studies and determination of sensitivity to antibiotics. α-hemolytic streptococci (S. constellatus, S. intermedius), Corynebacteria (Corynebacterium spp.), in association with periodontal pathogenic species T. forsythia, P. gingivalis and A. actinomycetemcomitans, as well as enterobacteria in significant numbers, were isolated. Sensitivity to the studied drugs: Ciprofloxacin-highly sensitive, Tinidazole-sensitive (except for enterobacteria), Amoxicillin/clavulanate-highly sensitive.

After professional hygiene, Cifran CT is prescribed for 1 tablet 2 times a day for 12 days.

When re-examined, the degree of microbial contamination corresponds to the normal level (4·10CFU/ml), the microbiota is mainly represented by α-green streptococci (S. sanguis, S. salivarius) in association with C. albicans in a small amount (100 CFU/ml). Clinically, the inflammatory process was stopped.

Clinical case 2

Patient V., 52 years old, with moderate CGP. In the preliminary study, the periodontopathogenic flora representatives were identified — α-hemolytic streptococci (S. sanguis, S. intermedius), β-hemolytic streptococci, in association with periodontopathogenic species of pigment-forming bacteroids T. forsythia, A. actinomycetemcomitans and P. intermedia, fungi of the genus Candida. the bacterial microbiota's sensitivity to the studied antimicrobial drugs: Ciprofloxacin-highly sensitive, Tinidazole-highly sensitive, Amoxicillin/clavulanate sodium — highly sensitive.

After professional hygiene, Amoxiclav is prescribed 1 tablet 2 times a day for 12 days.

After the end of the course of antimicrobial chemotherapy, α-hemolytic streptococci were not detected; periodontal pathogenic bacteria's association is determined. T. forsythia Candida spp. in high amounts (3·10CFU/ml). Clinically, the inflammatory process signs remain but without the release of exudate from the periodontal pockets.

Discussion

In the first clinical case, when using Cifran CT, there was a complete rehabilitation of periodontal pockets. Periodontopathogens were not determined. In the second case, despite the sensitivity of the isolated species of periodontopathogens to Amoxicillin, the periodontopathogen of the 1st order — T. forsythia, which is prone to intracellular parasitism, was preserved, and the number of Candida spp. increased sharply, which indicates the development of dysbiosis. In recent years, researchers have found more and more evidence for the role of fungal or mycobiofilm formed by yeast fungi as a basis for colonization by other pathogens [25—27].

Experimental data obtained in our previous studies using scanning electron microscopy indicate that Ciprofloxacin concentration with Tinidazole (Cifran CT) approaching the MSC determines the complete destruction of the biofilm mantle and partial damage to the microbial cells of P. gingivalis [20]. This confirms the drug's active effect on the polymicrobial biofilm of the periodontium and indicates its high antimicrobial and antibiotic film effectiveness.

Probably, given the almost identical sensitivity of most periodontal pathogens to these drugs, this can be explained by the different ability of the drugs used to penetrate the microbial biofilm and affect its matrix. It should also be considered that all groups of obligate anaerobes colonizing the oral cavity (classes of bacteroids, fusobacteria, clostridium, etc.) are highly sensitive to Tinidazole [2, 3, 28].

The use of Amoxicillin with clavulanic acid (despite the relatively high sensitivity of many periodontopathogens) is apparently limited because it acts only on extracellularly located bacteria and bacteria in the upper layers of the biofilm. Simultaneously, the combined preparation of fluoroquinolone (Ciprofloxacin) with Tinidazole withal leads to the death of intracellularly located periodontopathogens and the destruction of the biofilm matrix.

Thus, summarizing the above material and literature data, we can conclude that for effective eradication of periodontal pathogenic species of microorganisms, it is necessary to overcome the following factors that determine the development of periodontal pathology:

  • intracellular location of periodontopathogenic microbes [2, 12, 18];
  • protective effect of microbial biofilm [7, 9, 14, 16 ,22];
  • deep penetration of microbes into tissues (not available for mechanical and local antimicrobial action [5, 11];
  • a short duration of action and a decrease in the concentration of the antimicrobial agent when applied topically due to dilution with oral fluid [2, 3, 6];
  • decreased activity of local factors of mucosal immunity and activation of the proinflammatory cytokine cascade [12, 29—31].

Conclusion

Thus, after 2 weeks of the systemic use of antibacterial chemotherapy drugs, in the case of beta-lactams, a pronounced dysbiotic shift was observed with an increase in the population of yeast fungi, which persisted in group II after 1 month, while in group I (main) — normalized.

The inclusion of combined antimicrobial chemotherapy of Ciprofloxacin with Tinidazole (Cifran CT) in the algorithms of complex treatment of chronic generalized periodontitis increases the effectiveness of eradication of the periodontal pocket and periodontal complex tissues, both due to damage to the biofilm matrix and easier penetration into the biofilm (compared to beta-lactam antibiotics) and due to the synergistic effect of the drug components on the bacterial cells of pathogens themselves.

References

  1. Zoryan E.V., Tsarev V.N. Medication for periodontal disease. — In: Janushevich O.O., Dmitrieva L.A. (eds). Periodontology. National Guide. — Moscow: GEOTAR-Media, 2018. — Pp. 421—496 (In Russ.).
  2. Yakovlev S.V., Briko N.I., Sidorenko S.V., Protsenko D.N. (eds.) SCAT program (strategy of control of antimicrobial therapy) in the provision of inpatient medical care. Russian clinical guidelines. — Moscow: Quill, 2018. — Pp. 21—32 (In Russ.).
  3. Ushakov R.V., Tsarev V.N. Antimicrobial therapy in dentistry. Principles and algorithms. — Moscow: Practical medicine, 2019. — Pp. 21—35 (In Russ.).
  4. Kassebaum N.J., Bernabé E., Dahiya M., Bhandari B., Murray C.J.L., Marcenes W. Global burden of severe periodontitis in 1990—2010: a systematic review and meta-regression. — J Dent Res. — 2014; 93 (11): 1045—53. PMID: 25261053
  5. Keestra J.A.J., Grosjean I., Coucke W., Quirynen M., Teughels W. Non-surgical periodontal therapy with systemic antibiotics in patients with untreated chronic periodontitis: a systematic review and meta-analysis. — J Periodontal Res. — 2015; 50 (3): 294—314. PMID: 25142259
  6. Tsarev V.N., Atrushkevich V.G., Ippolitov E.V., Podporin M.S. Comparative analysis of periodontal antiseptic antimicrobial activity using the automated control of microbial growth in real-time. — Parodontologiya. — 2017; 1 (82): 4—10 (In Russ.).
  7. Kovalevskiy A.M., Ushakova A.V. et al. Bacterial biofilm of periodontal pockets: the revision of periodontology experience. — Parodontologiya. — 2018; 2 (87): 15—21 (In Russ.).
  8. Ushakov R.V., Tsarev V.N. Antiseptics usage in dentistry. — Moscow: Practical medicine, 2018. — Pp. 121—160 (In Russ.).
  9. Ramich T., Schacher B., Scharf S., Röllke L., Arndt R., Eickholz P., Nickles K. Subgingival plaque sampling after combined mechanical and antibiotic nonsurgical periodontal therapy. — Clin Oral Investig. — 2015; 19 (1): 27—34. PMID: 24554003
  10. Zakirov T.V., Voroshilina E.S., Brusnitsyna E.V., Ioshchenko E.S., Ozhgikhina N.V. Evaluation of the effectiveness of the main systemic antibiotics at the first stage of treatment of generalized aggressive periodontitis. — Parodontologiya. — 2019; 3: 213—21 (In Russ.).
  11. Orekhova L.Yu., Loboda E.S., Kosova E.V., Vashneva V.Yu., Petrov A.A. Topical antibiotic therapy in periodontology. — Parodontologiya. — 2020; 3: 217—23 (In Russ.).
  12. Hake S.K., Meyer D.H., Fives-Taylor P.M. Periodontal pathology. — In: Lamont R.J., Burne R.A., Lantz M.S., LeBlank D.J. (eds.) Oral microbiology and immunology. — ASM Press: Washington (DC), 2019. — Pp. 297—339.
  13. Tsarev V.N., Ippolitov E.V., Nikolaeva E.N. Prevalence of genetic markers of resistance to antibiotics in biofilm-forming strains of obligate and elective anaerobes. — Journal of Microbiology, Epidemiology and Immunobiology. — 2017; 2: 74—80 (In Russ.).
  14. Stewart P.S. Antimicrobial Tolerance in Biofilms. — Microbiol Spectr. — 2015; 3 (3): 10.1128/microbiolspec.MB-0010-2014. PMID: 26185072
  15. Li J., Wang X., Wang L. et al. High in vitro antibacterial activity of Pac—525 against Porphyromonas gingivalis biofilms cultured on titanium. — Biomed Res Int. — 2015; 2015: 909870. PMID: 25710035
  16. Pöllänen M.T., Paino A., Ihalin R. Environmental stimuli shape biofilm formation and the virulence of periodontal pathogens. — Int J Mol Sci. — 2013; 14 (8): 17221—37. PMID: 23965982
  17. Montagner F., Jacinto R.C., Signoretti F.G.C. et al. Beta-lactamic resistance profiles in Porphyromonas, Prevotella, and Parvimonas species isolated from acute endodontic infections. — J Endod. — 2014; 40 (3): 339—44. PMID: 24565649
  18. Socransky S.S., Haffajee A.D., Cugini M.A., Smith C., Jr R.L.K. Microbial complexes in subgingival plaque. — J Clin Periodontol. — 1998; 25 (2): 134—44. PMID: 9495612
  19. Zueva A.O., Chuvilkin V.I., Podporin M.S. et al. Microbiological evaluation of II and III generation quinolones in prevention and treatment of inflammatory complication in oral surgery. — Bacteriology. — 2017; 4: 50—4 (In Russ.).
  20. Tsarev V.N., Ushakov R.V., Ippolitov E.V., Podporin M.S., Nuruev N.N. Pilot study of antimicrobic and anti-biofilm activity of a combination of ciprofloxacin and tinidazolum in vitro. — Parodontologiya. — 2019; 4: 285—92 (In Russ.).
  21. Fàbrega A., Madurga S., Giralt E., Vila J. Mechanism of action of and resistance to quinolones. — Microb Biotechnol. — 2009; 2 (1): 40—61. PMID: 21261881
  22. Sharma D., Misba L., Khan A.U. Antibiotics versus biofilm: an emerging battleground in microbial communities. — Antimicrob Resist Infect Control. — 2019; 8: 76. PMID: 31131107
  23. Sanz M., Beighton D., Curtis M.A. et al. Role of microbial biofilms in the maintenance of oral health and in the development of dental caries and periodontal diseases. Consensus report of group 1 of the Joint EFP/ORCA workshop on the boundaries between caries and periodontal disease. — J Clin Periodontol. — 2017; 44 Suppl 18: S5-S11. PMID: 28266109
  24. Modina T.N., Mamaeva E.V., Abdrahmanov A.K., Gilfanov B.R., Il‘inskaya O.N. Identifying Candida albicans of inflammatory periodontal diseases. — Clinical Dentistry (Russia). — 2019; 1 (89): 20—3 (In Russ.).
  25. Kean R., Rajendran R., Haggarty J., Townsend E.M., Short B., Burgess K.E., Lang S., Millington O., Mackay W.G., Williams C., Ramage G. Candida albicans mycofilms support Staphylococcus aureus colonization and enhances miconazole resistance in dual-species interactions. — Front Microbiol. — 2017; 8: 258. PMID: 28280487
  26. Ebersole J.L., Dawson D. 3rd, Emecen-Huja P., Nagarajan R., Howard K., Grady M.E., Thompson K., Peyyala R., Al-Attar A., Lethbridge K., Kirakodu S., Gonzalez O.A. The periodontal war: microbes and immunity. — Periodontol 2000. — 2017; 75 (1): 52—115. PMID: 28758303
  27. Mombelli A. Microbial colonization of the periodontal pocket and its significance for periodontal therapy. — Periodontol 2000. — 2018; 76 (1): 85—96. PMID: 29193304
  28. Rumyantsev V.A., Avakova D.R., Blinova A.V. Host response modulation in periodontology and implantology: potential of anti-inflammatory, antibacterial therapy and promising dosage forms. Revew. — Parodontologiya. — 2019; 24 (4): 372—7 (In Russ.).
  29. Balmasova I.P., Lomakin Y.A., Babaev E.A., Tsarev V.N., Gabibov A.G., Smirnov I.V., Knorre V.D., Ovchinnikova L.A., Gnuchev N.V., Khurs E.N., Deev M.S., Kostin N.N., Arutyunov S.D. «Shielding» of cytokine induction by the periodontal microbiome in patients with periodontitis associated with type 2 diabetes mellitus. — Acta Naturae. — 2019; 11 (4): 79—87. PMID: 31993238
  30. Silva N., Abusleme L., Bravo D., Dutzan N., Garcia-Sesnich J., Vernal R., Hernández M., Gamonal J. Host response mechanisms in periodontal diseases. — J Appl Oral Sci. — 2015; 23 (3): 329—55. PMID: 26221929

Received

January 20, 2021

Published on

March 1, 2021